CTNM
Contineum Therapeutics Inc.
$10.95
-$1.28(-10.43%)
75
Overall
60
Value
90
Tech
--
Quality
Market Cap
$340.56M
Volume
687.88K
52W Range
$3.35 - $16.25
Target Price
$22.67
Company Overview
| Mkt Cap | $340.56M | Price | $10.95 |
| Volume | 687.88K | Change | -10.43% |
| P/E Ratio | -8.1 | Open | $10.97 |
| Revenue | -- | Prev Close | $12.22 |
| Net Income | $-42.3M | 52W Range | $3.35 - $16.25 |
| Div Yield | N/A | Target | $22.67 |
| Overall | 75 | Value | 60 |
| Quality | -- | Technical | 90 |
No chart data available
Latest News
Contineum Therapeutics, Inc. Class A (CTNM) Gets a Buy from RBC Capital
TipRanks Auto-Generated Intelligence Newsdesk•3 days ago
Contineum Therapeutics, Inc. Class A (CTNM) Gets a Buy from RBC Capital
TipRanks Auto-Generated Intelligence Newsdesk•23 days ago
Contineum Therapeutics Reports Increased R&D Investment Amid Losses
TipRanks Auto-Generated Newsdesk•24 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $10.95 | -10.4% | 687.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW